Remedy's Q3 figures were softer than expected due to timing factors, but generally there was nothing surprising in the report. Remedy is now building the next growth leap of its strategy with the 5 major gaming projects under development. This will be reflected in rising costs between 2022 and 2023, but enable significant earnings growth particularly in 2025-2026, driven by increasing royalty income. Considering this long-term potential, we believe the current valuation of the stock is attractive.
Trade. (Remedy)
Remedy Entertainment Plc is a globally successful game company founded in 1995 and based in Espoo, Finland. We create story-driven console and computer games with renowned partners such as 505 Games, Microsoft, Rockstar Games and Smilegate. Remedy has two games under development, CrossFire 2 and Project 7, built using our proprietary Northlight game engine and tools. Our past games include Death Rally, Max Payne, Max Payne 2: The Fall of Max Payne, Alan Wake, Alan Wake’s American Nightmare and Quantum Break.